Featured Research

from universities, journals, and other organizations

VNS Therapy For Treatment-resistant Depression Proves Effective For Some Patients

Date:

August 31, 2005

Source:

UT Southwestern Medical Center

Summary:

Vagus nerve stimulation (VNS) therapy, a treatment recently approved by the Food and Drug Administration for treatment-resistant depression, produced a positive response in more than 25 percent of patients in a national, yearlong study led by UT Southwestern Medical Center psychiatrists.
Sixteen percent to 20 percent of the study group experienced total remission.

Share This

Karmen McGuffee, implanted in 1999 with a vagus nerve stimulator to treat depression, regularly visits Dr. Mustafa Husain, professor of psychiatry at UT Southwestern, for check-ups. Results of a study tracking patients implanted with the device appear in Biological Psychiatry.

Credit: Image courtesy of UT Southwestern Medical Center

DALLAS – Aug. 31, 2005 – Vagus nerve stimulation (VNS)therapy, a treatment recently approved by the Food and DrugAdministration for treatment-resistant depression, produced a positiveresponse in more than 25 percent of patients in a national, yearlongstudy led by UT Southwestern Medical Center psychiatrists.

Related Articles

Sixteen percent to 20 percent of the study group experienced total remission.

Resultsof the study, led by Dr. A. John Rush, vice chairman for research inpsychiatry at UT Southwestern, appear in the September issue ofBiological Psychiatry. Findings from two additional related studiesalso are included in the issue.

VNS therapy, which the FDAapproved for treatment of epileptic seizures in 1997 and for depressionin July, has been studied in clinical trials for treatment-resistantdepression since 1998. VNS therapy includes surgical implantation of asmall battery-operated pulse generator – similar to a pacemaker – in apatient's left upper chest. Thin, flexible wires from the device aretunneled into the neck and send mild, intermittent pulses to the neck'sleft vagus nerve. The vagus nerve in turn delivers these pulses aboutevery five minutes to the areas of the brain involved in the regulationof mood, motivation, sleep, appetite and other symptoms relevant todepression.

Karmen McGuffee, who had the vagus nerve stimulatorimplanted in 1999 after suffering from severe depression for more than15 years, said the device has restored her life. A participant in oneof the first clinical trials at UT Southwestern, she had taken morethan 10 types of antidepressant drugs before the surgery, with littlesuccess.

"It was like having the color come back into my world,"said Mrs. McGuffee, 35. "Before VNS therapy, I could barely functionand only then with a lot of help. At the time, I had nothing to lose.

"NowI feel brighter and lighter. I'm not constantly worried, and I lookforward to everyday activities. Things that other people take forgranted, such as managing a house, a family and a job all are nowpossible."

VNS therapy is only indicated for people who have notbeen helped by other depression treatments, said Dr. Rush. "If you havetreatment-resistant depression and need long-term treatment, VNS is anoption that should be considered. While it's not going to get everybodyinto remission, it's doing pretty well in very difficult-to-treatpatients," he said.

Two of the three studies in the currentjournal compared patients with major depressive disorder or bipolardisorder, all of whom were implanted with the vagus nerve stimulator.In the first trial, which included 235 people and only lasted for 10weeks, patients implanted with the stimulator received either activeVNS therapy or no therapy, meaning the device was not activated. Therewas little change in either group.

Dr. Rush's second multicentertrial, which included 205 of the same patients, provided active VNStherapy for a full year to all participants, measuring their symptomsof depression at regular intervals using several standard ratingscales. One rating scale showed a 27.2 percent reduction in symptomsamong participants and a 15.8 percent remission rate at year's end –suggesting that long-term treatment with VNS offers a greater benefitthan its short-term application. A second rating scale showed reductionin symptoms by 28.2 percent and a 20.3 percent remission rate.

"Thisis a very good response, given the type of highly resistant depressioninvolved," Dr. Rush said. "Participants in the trials were some of themost treatment-resistant depressed patients ever studied, with at leasthalf having been hospitalized for the disease at least once."

Thestudies also showed VNS to be well-tolerated, with few serious adversereactions, he said. Possible side effects, however, can include aslight voice alteration or temporary hoarseness, cough, tickling in thethroat or shortness of breath during exertion – symptoms which mayoccur intermittently when the stimulation is on.

The third study,of which Dr. Rush was a co-author, compared two groups of people withsimilar degrees of severe depression. One group was implanted with thevagus nerve stimulator as well as given other types of treatments fordepression, including medication and cognitive therapy. The secondgroup did not receive the device, but was treated for depression.Results showed a 27 percent reduction in depressive symptoms in the VNSgroup, compared to a 13 percent reduction in the second group.

"VNS treatment can be very useful in combinationwith antidepressants for a particular group of patients who arechronically depressed," he said. "It can provide new hope for a betterlife to those who are not responding to antidepressant medications."

Dr.Husain and Dr. Rush were involved in all three studies, which includedresearchers from more than 20 sites around the country. The studieswere supported in part by Cyberonics Inc., manufacturer of VNS Therapy.

More From ScienceDaily

More Mind & Brain News

Featured Research

Mar. 31, 2015 — Memory and as well as connections between brain cells were restored in mice with a model of Alzheimer's given an experimental cancer drug, researchers report. "With this treatment, cells under ... full story

Mar. 31, 2015 — A criminologist finds that solitary confinement does not deter inmates from committing further violence in prison. The prisoners in the study who received solitary confinement were no more -- or less ... full story

Mar. 31, 2015 — Alcoholism takes a toll on every aspect of a person's life, including skin problems. Now, a new research report helps explain why this happens and what might be done to address it. "The clinical ... full story

Mar. 31, 2015 — Human language likely developed quite rapidly into a sophisticated system, a linguist contends. Instead of mumbles and grunts, people deployed syntax and structures resembling the ones we use today, ... full story

Mar. 31, 2015 — Coronary heart disease and stroke, two of the leading causes of death in the United States, are diseases associated with heightened platelet reactivity. A new study in humans suggests an underlying ... full story

Mar. 31, 2015 — A new study had researchers seeking answers to why the therapeutic benefit afforded by SSRIs was so limited in children and teenagers. If researchers can uncover the biological mechanisms preventing ... full story

Mar. 31, 2015 — New research reveals high-quality early education is especially advantageous for children when they start younger and continue longer. Not only does more high-quality early education significantly ... full story

Mar. 31, 2015 — During prenatal development, the brains of most animals, including humans, develop specifically male or female characteristics. But scientists have known little about the details of how this ... full story

Mar. 31, 2015 — A history of depression may put women at risk for developing diabetes during pregnancy, according to research. This study also pointed to how common depression is during pregnancy and the need for ... full story

Featured Videos

AAA: Distracted Driving a Serious Teen Problem

AP (Mar. 25, 2015) — While distracted driving is not a new problem for teens, new research from the AAA Foundation for Traffic Safety says it&apos;s much more serious than previously thought. (March 25)
Video provided by AP

Many Don't Know They Have Alzheimer's, But Their Doctors Do

Newsy (Mar. 24, 2015) — According to a new study by the Alzheimer&apos;s Association, more than half of those who have the degenerative brain disease aren&apos;t told by their doctors.
Video provided by Newsy

A Quick 45-Minute Nap Can Improve Your Memory

Newsy (Mar. 23, 2015) — Researchers found those who napped for 45 minutes to an hour before being tested on information recalled it five times better than those who didn&apos;t.
Video provided by Newsy

Related Stories

Sep. 1, 2014 — Regulation of the autonomic nervous system with a device that delivers continuous, low-amplitude stimulation to the vagus nerve can significantly improve cardiac function and symptoms in patients ... full story

Nov. 21, 2013 — Scientists paired vagus nerve stimulation with playing tones to decrease the symptoms of tinnitus, a debilitating disorder of ringing in the ears affecting many U.S. veterans and seniors. VNS-tone ... full story

Oct. 1, 2013 — Researchers tested using vagus nerve stimulation as a possible technique to improve stroke recovery. The study showed that pairing vagus nerve stimulation with physical rehabilitation returned all ... full story

May 7, 2013 — For nearly a decade, doctors have used implanted electronic stimulators to treat severe depression in people who don't respond to standard antidepressant treatments. Now, preliminary brain scan ... full story

ScienceDaily features breaking news and videos about the latest discoveries in health, technology, the environment, and more -- from major news services and leading universities, scientific journals, and research organizations.